home / stock / xene / xene quote
Last: | $38.07 |
---|---|
Change Percent: | -0.31% |
Open: | $39.16 |
Close: | $38.07 |
High: | $39.6999 |
Low: | $37.53 |
Volume: | 777,464 |
Last Trade Date Time: | 05/31/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$38.07 | $39.16 | $38.07 | $39.6999 | $37.53 | 777,464 | 05-31-2024 |
$39.04 | $38.42 | $39.04 | $39.36 | $38.12 | 304,956 | 05-30-2024 |
$38.29 | $38.1 | $38.29 | $38.37 | $37.155 | 264,337 | 05-29-2024 |
$38.61 | $38.77 | $38.61 | $39.18 | $38.1494 | 331,221 | 05-28-2024 |
$38.37 | $38.34 | $38.37 | $40.12 | $38.11 | 193,372 | 05-27-2024 |
$38.37 | $38.34 | $38.37 | $40.12 | $38.11 | 193,372 | 05-24-2024 |
$38.46 | $39.01 | $38.46 | $39.3899 | $37.53 | 591,856 | 05-23-2024 |
$38.8 | $39.1 | $38.8 | $39.57 | $38.51 | 418,657 | 05-22-2024 |
$38.98 | $40.35 | $38.98 | $40.66 | $38.75 | 359,807 | 05-21-2024 |
$40.42 | $39.75 | $40.42 | $40.43 | $39.07 | 469,380 | 05-20-2024 |
$39.8 | $40.08 | $39.8 | $40.56 | $39.48 | 261,461 | 05-17-2024 |
$40.34 | $40.29 | $40.34 | $41.095 | $39.5 | 505,234 | 05-16-2024 |
$40.45 | $41.08 | $40.45 | $41.87 | $40.15 | 329,567 | 05-15-2024 |
$40.58 | $41.05 | $40.58 | $42.45 | $40.48 | 295,385 | 05-14-2024 |
$40.48 | $41.05 | $40.48 | $42.12 | $40.48 | 316,882 | 05-13-2024 |
$40.54 | $40.76 | $40.54 | $42.56 | $38.6 | 527,882 | 05-10-2024 |
$42.49 | $42.93 | $42.49 | $43.02 | $42.24 | 182,754 | 05-09-2024 |
$42.93 | $43.21 | $42.93 | $43.21 | $42.18 | 113,596 | 05-08-2024 |
$43.43 | $43.4 | $43.43 | $43.63 | $42.645 | 140,345 | 05-07-2024 |
$43.19 | $43.87 | $43.19 | $44.3672 | $42.67 | 266,970 | 05-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Xenon Pharmaceuticals Inc. Company Name:
XENE Stock Symbol:
NASDAQ Market:
Xenon Pharmaceuticals Inc. Website:
VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical...
VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced data presentations highlighting azetukalner (XEN1101) clinical data in major depressive disorder (MDD) at the American Society of Cli...
2024-05-15 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...